Health

Low- and No-Calorie Artificial Sweeteners Intake Linked to Cognitive Decline

A Brazilian longitudinal cohort study suggested that consumption of low- and no-calorie sweeteners (LNCSs) was associated with accelerated cognitive decline. A total of 12,772 civil servants (mean age 52 years, 55% women) were followed over three study waves across eight years. Using dietary questionnaires and cognitive testing, researchers found that younger participants (<60 years) consuming higher amounts of LNCSs had a faster decline in verbal fluency and global cognition, with artificial LNCSs (aspartame, saccharin, acesulfame K) and sugar alcohols (erythritol, sorbitol, xylitol) particularly linked to declines in memory and verbal fluency. The associations were seen in both participants with and without diabetes, though patterns differed by subgroup. No associations were observed in participants aged 60+. The findings raised concerns about potential long-term effects of artificial sweeteners on brain health. Source: https://www.neurology.org/

hyangiu

Recent Posts

Early-Life Sugar Restriction Linked to Lower Risk of Early-Onset Cancer

Early-life sugar restriction during pregnancy and infancy was associated with a 34% lower risk of…

2 days ago

Domain-Specific Physical Activity and Dementia Risk

Higher levels of physical activity were associated with lower risks of all-cause dementia, Alzheimer’s disease,…

5 days ago

BMI and Waist Circumference Jointly Predict Mortality Risk in Older Adults

In US adults aged ≥65 years, overweight and class I–II obesity were associated with lower…

5 days ago

Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined…

6 days ago

The Obesity Paradox in Colorectal Cancer May Reflect Prediagnostic Weight Loss

In the German multicenter study of 5,521 patients with colorectal cancer (CRC), the apparent survival…

1 week ago

Stopping Statins for Primary Prevention After Age 75? Evidence from a Randomized Trial

In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD)…

2 weeks ago

This website uses cookies.